A study is seeking to contribute to cancer immunotherapy in the development of vaccines against deadly cancer types such as ...

The method triggers immune responses that inhibit melanoma, triple-negative breast cancer, lung carcinoma, and ovarian cancer ...

RNA cancer vaccines are at the forefront of next-generation cancer immunotherapy, showcasing significant potential.

EVM14 received FDA clearance for clinical trials, marking Everest Medicines’ first in-house developed therapeutic to reach ...

Full-year results and business updateClinical proof of principle obtained in Phase I adjuvant head and neck cancer trial with individualized ...

HPV, one of the most prevalent sexually transmitted infections, is the cause of nearly 36,000 cancer cases each year in the United States.

NEC has developed a system to use face biometrics to authenticate patients for personalized cancer vaccine therapy without ...

Anixa Biosciences secured a USPTO patent allowance for its ovarian cancer vaccine, strengthening its IP position and ...

Glenn Moog didn't know much about HPV cancer — until he was diagnosed with it. The 59-year-old husband, father and realtor ...

Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine. Anixa Biosciences, Inc. March 24, 2025.

Marek’s disease can be pervasive in chicken houses. Chickens infected by this highly contagious viral disease often develop ...

In their messages during Eid al-Fitr prayers yesterday, key preachers also touched on social issues ranging from the ...